gastrointestinal cancer

Researchers associated with the Cancer Genome Atlas (TCGA) Research Network will publish more than 25 papers this week to discuss findings from the initiative.

The firm's Guardant360 assay will be used first to test patients for ERBB2 mutations, then guide patients to a variety of treatment arms.

The partners aim to identify master regulators in the molecular networks of GIST patients that can serve as drug targets for existing treatments.

This Week in Science

In Science this week: immunogenic mutations in GI cancers, and more.

The research may lay the groundwork for a noninvasive test for GI or other types of cancer without prior knowledge of which organ is affected.

The agreement expands the partners' alliance to include additional diseases within the gastrointestinal tract.

In GIST tumors lacking genetic mutations, researchers uncover an epimutation affecting a gene promoter.

Indivumed and Georgetown have already established a biobank and clinical database for analyzing tumor specimens to improve cancer diagnostics.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.